OCX insider transaction filings

Oncocyte Corp — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-03-28. Screen OCX transaction legs live →

FiledFormInsiderReported transactionsSource
2025-03-284Riggs Josh — CEO and PresidentGrant/award (A): 188,679 (derivative) @ $0EDGAR
2025-03-284James Andrea S. — Chief Financial OfficerGrant/award (A): 113,207 (derivative) @ $0EDGAR
2025-03-284Liu James Yang — VP ACCT, Cntlr, Treasurer, PAOGrant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 18,867 (derivative) @ $0EDGAR
2025-02-114James Andrea S. — Chief Financial OfficerPurchase (P): 97,561 @ $2.05EDGAR
2025-02-114SMITH PATRICK W — 10% ownerPurchase (P): 1,077,600 @ $2.05 · Other (J): 385,814 @ $2.05EDGAR
2025-02-104BROADWOOD PARTNERS, L.P. — 10% owner
BROADWOOD CAPITAL INC — 10% owner
BRADSHER NEAL C — 10% owner
Purchase (P): 660,207 @ $2.05 · Purchase (P): 0 @ $0 · Purchase (P): 4,505,488 @ $2.05 · Purchase (P): 0 @ $0EDGAR
2025-02-044SMITH PATRICK W — 10% ownerPurchase (P): 890 @ $2.01 · Purchase (P): 25 @ $2.02EDGAR
2025-01-314SMITH PATRICK W — 10% ownerPurchase (P): 3,880 @ $2.01 · Purchase (P): 318 @ $2.01EDGAR

Recent 8-K events — Oncocyte Corp

FiledFormItems reportedSource
2026-08-108-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K/A8.01 — Other EventsEDGAR
2026-04-308-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-268-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-128-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-118-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=OCX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →